- Home
- OCGN vs NAMI Comparison
OCGN vs NAMI Comparison
Compare OCGN & NAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- NAMI
- Stock Information
- Founded
- OCGN 2013
- NAMI 2014
- Country
- OCGN United States
- NAMI China
- Employees
- OCGN N/A
- NAMI N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- NAMI
- Sector
- OCGN Health Care
- NAMI
- Exchange
- OCGN Nasdaq
- NAMI NYSE
- Market Cap
- OCGN 246.8M
- NAMI 286.0M
- IPO Year
- OCGN N/A
- NAMI 2024
- Fundamental
- Price
- OCGN $0.89
- NAMI $4.14
- Analyst Decision
- OCGN Strong Buy
- NAMI
- Analyst Count
- OCGN 3
- NAMI 0
- Target Price
- OCGN $5.67
- NAMI N/A
- AVG Volume (30 Days)
- OCGN 6.1M
- NAMI 283.6K
- Earning Date
- OCGN 11-08-2024
- NAMI 02-11-2025
- Dividend Yield
- OCGN N/A
- NAMI N/A
- EPS Growth
- OCGN N/A
- NAMI N/A
- EPS
- OCGN N/A
- NAMI 0.37
- Revenue
- OCGN $4,700,000.00
- NAMI $56,127,097.00
- Revenue This Year
- OCGN N/A
- NAMI N/A
- Revenue Next Year
- OCGN N/A
- NAMI N/A
- P/E Ratio
- OCGN N/A
- NAMI $10.83
- Revenue Growth
- OCGN N/A
- NAMI 64.40
- 52 Week Low
- OCGN $0.49
- NAMI $3.70
- 52 Week High
- OCGN $2.11
- NAMI $7.75
- Technical
- Relative Strength Index (RSI)
- OCGN 54.92
- NAMI N/A
- Support Level
- OCGN $0.79
- NAMI N/A
- Resistance Level
- OCGN $0.88
- NAMI N/A
- Average True Range (ATR)
- OCGN 0.08
- NAMI 0.00
- MACD
- OCGN 0.01
- NAMI 0.00
- Stochastic Oscillator
- OCGN 65.97
- NAMI 0.00
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About NAMI JINXIN TECHNOLOGY HOLDING COMPANY SPONSORED ADS EACH REP 18 ORD SHS
Jinxin Technology Holding Co is a company which operates through its subsidiaries are principally engaged in provision of digital textbook subscription services in the People's Republic of China. The Company generates revenue by selling its content to hardware manufacturers in China whereby they are allowed to install the Company's digital educational content on the manufacturers' devices for sale to end users.